14 U-M Medical School faculty named fellows of the American Association for the Advancement of Science – Michigan Medicine Headlines

Fourteen medical school faculty members are among a national-best 20 from U-M elected as 2021 fellows of the American Association for the Advancement of Science (AAAS).

The U-M researchers are among 564 scientists, engineers and innovators, spanning 24 scientific disciplines, recognized for their scientifically and socially distinguished achievements, AAAS announced Jan. 26.

AAAS is the worlds largest general scientific society and publisher of theSciencefamily of journals. Selection as an AAAS fellow is among the most distinct honors within the scientific community.

The new AAAS fellows from the medical school are:

Veera Baladandayuthapani, Ph.D.,professor of biostatistics, School of Public Health; professor of computational medicine and bioinformatics, Medical School; director of the Cancer Data Science Shared Resource at the Rogel Cancer Center, for distinguished contributions to the field of biostatistics and data science, particularly for Bayesian modeling of high-dimensional biomedical data, integrative genomics and applied cancer research.

Charles Burant, M.D., Ph.D., Dr. Robert C. and Veronica Atkins Professor of Metabolism, professor of internal medicine, and of molecular and integrative physiology and director of the A. Alfred Taubman Medical Research Institute, Medical School; and professor of nutritional sciences, School of Public Health, for distinctive molecular and metabolomic research on insulin resistance, therapy for diabetes and management of obesity combined with stimulation of physical activity.

Mats Ljungman, Ph.D.,professor of radiation oncology, Medical School; and professor of environmental health sciences, School of Public Health, for distinguished contributions to the field of computational medicine and bioinformation through scientific and leadership achievements through contributions and dedication to the RNA community of research.

George Mashour, M.D., Ph.D.,Robert B. Sweet Professor of Anesthesiology, professor of anesthesiology, of neurosurgery and of pharmacology, Medical School; adjunct professor of psychology, LSA, for distinguished contributions to the fields of academic anesthesiology and neuroscience, particularly for studies across the translational spectrum identifying network-level mechanisms of how general anesthetics disrupt consciousness.

Sofia Merajver, M.D., Ph.D.,GreaterGood Breast Cancer Research Professor and professor of internal medicine, Medical School; professor of epidemiology, School of Public Health, for landmark studies of mechanisms, novel therapies and biomarkers, and management of patients with inflammatory breast cancers and women at increased risk for cancers in the United States and Africa.

David Musch, Ph.D., MPH,professor of ophthalmology and visual sciences, Medical School; professor of epidemiology, School of Public Health, for distinguished contributions to the field of clinical epidemiology, particularly by using innovative design principles and analytical techniques to provide evidence-based guidance for the prevention and treatment of ophthalmic disease.

Melanie Diane Ohi, Ph.D.,Rowena G. Matthews Collegiate Professor in the Life Sciences, Life Sciences Institute; professor of cell and developmental biology, Medical School, for distinguished contributions to the field of structural biology, particularly structure/function discoveries about secretion systems of pathogenic bacteria, and for expanding access to cryo-electron microscopy through education.

Ling Qi, Ph.D.,professor of molecular and integrative physiology, and of internal medicine, Medical School, for distinguished contributions to the field of medicine by producing new insights into the importance of ER-associated protein degradation in disease pathogenesis.

Patrick Schloss, Ph.D.,Frederick G. Novy Collegiate Professor of Microbiome Research, professor of microbiology and immunology, Medical School, for distinguished contributions to computational biology, particularly for development of computational programs for analysis of DNA sequence of mixed bacterial populations.

Susan Shore, Ph.D.,Merle Lawrence Collegiate Professor of Otolaryngology Research, professor of otolaryngology-head and neck surgery, Kresge Hearing Research Institute; professor of molecular and integrative physiology, Medical School; and professor of biomedical engineering, College of Engineering, for distinguished contributions to the field of sensory neuroscience, particularly in the roles and mechanisms brainstem circuitry for audition and mechanisms underlying tinnitus and hyperacusis.

Katherine Spindler, Ph.D.,professor of microbiology and immunology, Medical School, for distinguished contributions to the field of viral pathogenesis and virus-host interactions and for outstanding contributions in mentoring, professional service and scientific communication.

Stephan Taylor, M.D.,professor of psychiatry, Medical School; adjunct professor of psychology, LSA, for distinguished contributions in research for developing and improving treatments for psychiatric disorders.

John Voorhees, M.D.,Duncan O. and Ella M. Poth Distinguished Professor of Dermatology and professor of dermatology, Medical School, for extraordinary contributions to skin biology and dermatology, in particular psoriasis, the skin response to ultraviolet radiation, and skin aging, and an exemplary and sustained record of leadership in dermatology.

Bing Ye, Ph.D.,Burton L. Baker Collegiate Professor of the Life Sciences, Life Sciences Institute; and professor of cell and developmental biology, Medical School, for distinguished contributions to the field of developmental neuroscience, particularly for the molecular basis of the specification of axonal and dendritic morphology, and for their functional characteristics.

The new fellows will be celebrated later this year during an in-person gathering when it is feasible from a public health and safety perspective. The new class also will be featured in the AAAS News & Notes section ofSciencein January.

Original post:
14 U-M Medical School faculty named fellows of the American Association for the Advancement of Science - Michigan Medicine Headlines

World Anti-Aging & Longevity Complementary and Alternative Medicine Market Report 2022 – ResearchAndMarkets.com – Business Wire

DUBLIN--(BUSINESS WIRE)--The "Complementary And Alternative Medicine For Anti Aging & Longevity Market Size, Share & Trends Analysis Report by Intervention (Botanicals, Mind Healing), by Customer, by Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

The global complementary and alternative medicine for anti aging and longevity market size is expected to reach USD 182.9 billion by 2028. It is expected to expand at a CAGR of 22.2% from 2021 to 2028.

Growing household income in developed countries, acceptance of herbal and ayurvedic medicine, and increasing age-related diseases have majorly the market for complementary and alternative medicine (CAM) for anti aging and longevity.

In the traditional alternative medicine/botanicals intervention segment, Ayurveda led the market in 2020 as cosmetic market players are involved in the R&D of Ayurveda-based anti-aging cosmeceuticals. The mind healing segment is expected to witness steady growth from 2021 to 2028 due to the rising acceptance of meditation and mindfulness in corporate offices.

The sensory healing segment is expected to expand at a considerable CAGR over the forecast period due to the increasing popularity in hospitals and clinics. For instance, in October 2021, Spatial, an audio platform, partnered with HealthTune scientific and Catalyst by Wellstar to use sensory healing to reduce stress and anxiety of frontline healthcare workers.

Ayurveda is acknowledged as a medicine in 16 countries including Brazil, Switzerland, Hungary, Nepal, Bahrain, UAE, and Saudi Arabia. Whilst, some regions such as Romania, Hungary, Ontario, and Turkey regulate ayurvedic practices. In the U.K., it is a part of the National Health Policy.

Thus, increasing acceptance of ayurvedic medicine is expected to drive the complementary and alternative medicine market to a major extent. In addition, insurance coverage by public and private players is anticipated to fuel market growth.

COVID-19 has become a catalyst for the implementation of CAM therapies in day-to-day life. Owing to the pandemic, online yoga classes witnessed a 25% increase in enrollment level.

Similarly, in the COVID-19 pandemic, the demand for yoga equipment accelerated by154%. Key players and governing regulatory bodies are undertaking various strategic initiatives such as regional expansion to develop their presence in the market.

Complementary And Alternative Medicine For Anti Aging & Longevity Market Report Highlights

Key Topics Covered:

Chapter 1 Methodology And Scope

Chapter 2 Executive Summary

Chapter 3 Market Variables, Trends, & Scope

3.1 Market Lineage Outlook

3.1.1 Parent Market Outlook

3.1.2 Related/Ancillary Market Outlook

3.2 Market Dynamic

3.2.1 Market Driver Analysis

3.2.1.1 Increasing aging population and related diseases

3.2.1.2 Increasing awareness of traditional medicines

3.2.1.3 Government Initiatives and Encouraging Regulation

3.2.2 Market Restraints

3.2.2.1 FDA and medically approved drugs for aging

3.2.2.2 Target anti-aging related diseases indirectly (not the primary solution)

3.2.3 Market Opportunity

3.2.3.1 Development of Meditation centers

3.2.4 Market Threat

3.2.4.1 Rising consumption of anti age cosmetics

3.3 Penetration and Growth Prospect Mapping for Test Type 2020 (USD Million)

3.4 COVID-19 Impact Analysis

3.5 Business Environment Analysis

3.5.1 Swot Analysis; By Factor (Political & Legal, Economic And Technological)

3.5.2 Porter's Five Forces Analysis

3.6 Pricing Analysis

3.7 Antiaging Medicine

3.7.1 Integrative Medicine

3.7.2 Holistic Medicine

3.7.3 Functional Medicine

3.7.4 Nutritional Therapy

3.7.5 Exercise Therapy

3.7.6 Mental Therapy

Chapter 4 Intervention Business Analysis

4.1 Complementary And Alternative Medicine Market for Antiaging and Longevity: Intervention Movement Analysis

4.2 Traditional Alternative Medicine/Botanicals

4.2.1 Global Traditional Alternative Medicine/Botanicals Market For Antiaging And Longevity Estimates And Forecast, 2017-2028 (USD Million)

4.2.2 Ayurveda

4.2.3 Naturopathic Medicine

4.2.4 Traditional Chinese Medicine

4.2.5 Zang Fu Theory

4.3 Body Healing

4.3.1 Global Body Healing Cam Market For Antiaging And Longevity Estimates And Forecast, 2017-2028 (USD Million)

4.3.2 Yoga

4.3.3 Acupuncture & Massage

4.3.4 Chiropractic

4.3.5 Qigong & Tai Chi

4.3.6 Kinesiology

4.3.7 Reflexology

4.3.8 Eurythmy

4.4 Mind Healing

4.4.1 Global Mind Healing Based Market For Antiaging And Longevity Estimates And Forecast, 2017-2028 (USD Million)

4.4.2 Meditation & Mindfulness

4.4.3 Relaxation

4.5 External Energy Healing

4.5.1 Global External Energy Healing Based Market For Antiaging And Longevity Estimates And Forecast, 2017-2028 (USD Million)

4.5.2 Magnetic & Electromagnetic Therapy

4.5.3 Chakra Healing

4.5.4 Reiki

4.6 Sensory Healing

4.6.1 Global Sensory Healing Based Market For Antiaging And Longevity Estimates And Forecast, 2017-2028 (USD Million)

4.6.2 Aromatherapy

4.6.3 Sound Healing

Chapter 5 Customers Business Analysis

5.1 Complementary And Alternative Medicine Market for Antiaging and Longevity: Customer Movement Analysis

5.2 High net worth (HNW) individuals

5.3 Very high net worth (VHNW) individuals

5.4 Ultra-High Net Worth (Uhnw) Individuals

Chapter 6 Regional Business Analysis

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/urnnks

Continued here:
World Anti-Aging & Longevity Complementary and Alternative Medicine Market Report 2022 - ResearchAndMarkets.com - Business Wire

COVID Symptoms That Patients Say are "The Worst" Eat This Not That – Eat This, Not That

The COVID surge is still taking place in many parts of the country and largely because of Omicron. Dr. Michael Hirt, a Board Certified Nutrition from Harvard University and Board Certified in Internal Medicine and is with The Center for Integrative Medicine in Tarzana California explains why. "As arguably the most contagious virus in human history, Omicron has achieved this moniker by expressing 32 mutations in the spike protein array that surrounds its viral core. These spike proteins target the cell surfaces of our respiratory system and these spike proteins are also the target themselves of our immune system which can then neutralize and remove the viruses. Unfortunately, these 32 mutations have transformed Omicron in two important ways that make it much easier to catch Omicron and pass it on to others." As millions come down with COVID, doctors tell Eat This, Not That! Health what the worst symptoms are and signs to watch out for. Read onand to ensure your health and the health of others, don't miss these Sure Signs You've Already Had COVID.

Dr. Yasmin Akhunji, a board-certified endocrinologist with Paloma Health says, "I've now seen many patients in the clinic a year after they originally contacted COVID-19. The lung impact and neurological impact it has as a remnant effect is terrible. With this new variant, while it is short-lived in comparison, it is highly contagious."

Dr. Akhunji explains, "Brain fog is no joking matter, and while people feel like the symptoms are short-lived, we are finding that some have long-term neurologic deficits." Brain fog can include an inability to concentrate, remember things, feel clear-headed. "Why risk it? Keep yourself and your loved ones safe."

RELATED: Never Say These Words to a Doctor

Dr. Teresa Bartlett, senior medical officer at Sedgwick explains, "The majority of people are exhibiting a severe sore throat and describe it like swallowing razor blades, stuffy nose, fever, body aches and a cough. Often the virus starts with a headache and many think they have a sinus infection. Be on the lookout for these symptoms. I have spoken to so many patients who think if they did not lose taste or smell they can't possibly have COVID but that simply is not true."

RELATED: Surprising Side Effects of Marijuana, Say Studies

Infectious disease expert and pioneering scientific researcher Dr. Serhat Gumrukcu states, "Omicron is currently the most dominant variant of COVID-19. Omicron's infection rates have been widespread across the globe. This variant has been shown to have symptoms quite similar to previous COVID variants such as headaches, fevers with chills, colds, dry coughs and body aches. However, these symptoms seem to be milder for vaccinated individuals with recovery generally expected within 5-7 days. There have been very few cases of loss of taste and smell that have been reported with Omicron infections, unlike the Delta variant."

RELATED: Lose Your Visceral Fat Fastest This Way, Say Experts

According to Dr. Hirt, "First, the Omicron spike protein mutations give the virus a much stronger electric charge which causes a 'static cling' effect, binding the virus more tightly to the lining of our nose and mouth like a dryer sheet to a wool sweater. This makes the Omicron variant more contagious, so that it takes only a few viruses to start an infection because the virus is better able to 'cling' to our respiratory lining.

Second, our immune systems use a sort of 'natural' technology (much like facial recognition) to identify bugs like viruses and bacteria. The ability of the immune system to recognize a COVID virus can be programmed either by a naturally acquired COVID infection or by the COVID vaccines. So, the next time a COVID virus tries to enter our bodies, this 'viral' recognition technology helps our immune system rapidly identify COVID and neutralize the threat. Omicron's multitude of mutations create an effective disguise that can fool the immune system's 'viral' recognition programming. These mutations transform the physical appearance of the virus and allow it to sidestep both natural and vaccine-acquired immunity."

The CDC says: "Look for emergency warning signs* for COVID-19. If someone is showing any of these signs,seek emergency medical care immediately:

*This list is not all possible symptoms. Please call your medical provider for any other symptoms that are severe or concerning to you."

RELATED: Omicron Symptoms You Should Never Ignore

Follow the public health fundamentals and help end this pandemic, no matter where you liveget vaccinated or boosted ASAP; if you live in an area with low vaccination rates, wear an N95 face mask, don't travel, social distance, avoid large crowds, don't go indoors with people you're not sheltering with (especially in bars), practice good hand hygiene, and to protect your life and the lives of others, don't visit any of these 35 Places You're Most Likely to Catch COVID.

Read more from the original source:
COVID Symptoms That Patients Say are "The Worst" Eat This Not That - Eat This, Not That

Fact check: Claim that cilantro removes heavy metals from the brain is unproven – USA TODAY

Your brains fingerprint can be identified in just 100 seconds

Our brains are some of the most complicated things ever studied, but it turns out an fMRI can literally read you like a book.

Buzz60, Buzz60

A popular social media claim alleges cilantro is more than just a popular herb for cooking.

"Cilantro removes toxic heavy metals from the brain," reads the text of a Facebook post shared Dec. 29.

The post generated over 5,000 interactions and close to 1,600 shares in less than two weeks. Several other social media users shared this postas well.

Special access for subscribers!Click here to sign up for our fact-check text chat

But the claim doesn't tell the whole story.

Experts told USA TODAY researchers are still exploring the effectiveness of cilantro's healing properties in removing potential heavy metals from the brain.

USA TODAY reached out to the social media user who shared the post for comment.

USA TODAY reached out to 80 experts about the claim but received only four responses. Jane Flinn, director of cognitive and behavioral neuroscience at George Mason University, said in an email the idea seemed novel to her.

"I have to admit I had never heard of this," Flinn said. "Plants can absorb metals but I don't know how it would get it out of the brain."

Dr. Maida Galvez, professor of environmental medicine and public health at Mount Sinai, said in an email there is insufficient evidenceto prove the claim.

Through a search on PubMed, a search engine containing over 33 million research studies, USA TODAY found two articles that explorecilantro and heavy metal in the brain. Both studies used lead, a common heavy metal, as their primary agent.

Fact check: False claim that sexually transmitted diseases were made in a lab

Exposure to lead can produce oxidative stress, an imbalance of antioxidants that protect againstcell and tissue breakdown, according to Medical News Today. A 2014 study concluded that hydro-alcoholic seed extract from cilantro can alleviatelead-induced oxidative stress in certain tissues of rat brains.

The study didnot look at the properties of cilantro as a whole. And it focused on damage done after a heavy metal enters the brain rather thanwhether cilantro can remove heavy metals.

A more recent study published in 2021found cilantro provided protection against bothoxidative stress and negative changes in brain structurethatlead caused in the brains of mice.It did not address whether cilantro removes heavy metals directly from the brain.

Fact check: False claim that garlic can ease ear pain, infections and headaches

Chris D'Adamo, director of the Center for Integrative Medicine at the University of Maryland, said there is no certainty the same effects would present in humans, too, since the study was in mice.

Several other studies have found cilantro has an impact on heavy metals elsewhere in the body.

A 2010 study found that cilantro reduced the tissue levels of lead in the testes of mice to some extent. Researchers also published a study three years agothat concluded the intake of cilantro leaf extract contributed to a decrease of oxidative stress in the kidney, likely due toreduced concentration of heavy metals.

More studies would be helpful to confirm the findings,but there is some foundation to the claim being made about cilantro in light of this study and how we know it chelates heavy metals throughout the body," said D'Adamo.

Heavy metals can get intothe brain from exposure to environmental toxins, which can leachinto food, drinking water and the air, D' Adamo said.

These metals also have the ability tocross theblood-brain barrier, a feature of the human nervous system that defendsthe brain from pathogens and toxinsin the blood, according toa 2015 study.

The effects ofheavy metal in the brain vary.Leadcan result in a range of neurodevelopmental problems, such as attention deficit hyperactivity disorder and decreased IQ in children,Galvez said.

Mercury can "alter brain functionsand lead to tremors, shyness, irritability, memory problems and changes in hearing or vision,"according to a 2019 study.

Scientists have sought ways to reduce heavy metals in the body, given these negative outcomes.

Fact check: Rumor that Fox announced 'King of the Hill' reboot is false

One treatment to remove heavy metalsfrom the body is chelation therapy, in which a solutionis injected into the bloodstream that binds with the properties of a metal,according to University of Michigan Health.

Randomized control trials in children with lead poisoning havedemonstrated the effectivenessof chelation therapy atblood lead levels of 45 micrograms per deciliter or higher,Galvez said.

A 2019 research studyshows how chelation therapy can act as a "therapeutic agent"for neurotoxicity caused by heavy metals. Researchers are still exploring the efficacy of chelation therapy in removing heavy metals in the brain.

Based on our research, we rate MISSING CONTEXTthe claim that cilantro removes heavy metals from the brain. Scientists USA TODAY spoke to weren't aware of any studies that directly proved this claim and said more research is needed. However,some studies have found cilantro or its extracts have a positive effect on heavy metal levels in the body and brains of rodents.

Thank you for supporting our journalism. You can subscribe to our print edition, ad-free app or electronic newspaper replica here.

Our fact-check work is supported in part by a grant from Facebook.

Read more:
Fact check: Claim that cilantro removes heavy metals from the brain is unproven - USA TODAY

Introducing the Whole Health for Veterans with Chronic Pain podcast – VAntage Point – VAntage Point Blog

Veterans with chronic pain are searching for new ways to manage their conditions. The new Whole Health for Veterans with Chronic Pain podcast offers fresh perspectives on chronic pain management and various interventions, discussing self-care and practical strategies for Veterans and their well-being.

The new podcast takes a Veteran-centered Whole Health approach, providing skills and knowledge that encourage them to view healing as a journey that requires them to stay engaged, working toward wholeness.

The podcast also features topics about self-care and complementary and integrative treatments that can be incorporated into daily life to reduce the impact of chronic pain and improve overall health.

Studies have shown that chronic pain is a highly prevalent condition, estimated to affect over 50% of Veterans who receive care through VA. Many of them are seeking new ways to manage this lifelong condition. Veterans are using lifestyle choices and complementary and integrative health modalities such as acupuncture, yoga and therapeutic massage.

Whole Health for Veterans with Chronic Pain podcast

As part of VAs transformation to Veteran-centered Whole Health, these options are available.

Cherise Knotts is a 53-year-old Veteran who is engaged in Whole Health treatment for chronic pain and substance use that incorporates battlefield acupuncture, meditation, healing touch, nutrition and exercise.

I am accomplishing my short- and long-term goals, Knotts said. Im so proud of myself because, when I was using, I hardly finished anything. Life has its struggles with pain, but I am doing a lot of homeopathic medicines along with pharmaceuticals. Things are coming along just fine. I think the reason we overcome obstacles is so that we can be a beacon for others.

The podcast takes listeners through the Circle of Health and the eight components of self-care to teach self-care skills to manage chronic pain. The podcast is helpful for anyone who wishes to learn more and supplement their treatment plans. Podcast host, Dr. Carol Bowman, is a primary care physician at the Los Angeles VA and has worked with patients with chronic pain for over 10 years, and with Veterans for over six years.

In addition to primary care internal medicine training, Dr. Bowman studied and practiced holistic medicine for over 25 years and is certified in integrative pain management.

Our conventional approach using surgery and medications has failed for chronic pain, Bowman said. I have worked with hundreds of Veterans who have benefited from a Whole Health approach and are living their best lives. I wanted to bring these tools and information right to Veterans so they can embark on a healing journey right now.

Find your platform and subscribe to the podcast here.

Read more:
Introducing the Whole Health for Veterans with Chronic Pain podcast - VAntage Point - VAntage Point Blog

Complementary And Alternative Medicine For Anti Aging & Longevity Market Size Worth $182.9 Billion By 2028: Grand View Research, Inc. – PRNewswire

SAN FRANCISCO, Jan. 24, 2022 /PRNewswire/ --The global complementary and alternative medicine for anti aging and longevity marketsize is expected to reach USD 182.9 billion by 2028, as per a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 22.2% from 2021 to 2028. Growing household income in developed countries, acceptance of herbal and ayurvedic medicine, and increasing age-related diseases have majorly the market for complementary and alternative medicine (CAM) for anti aging and longevity.

Key Insights & Findings from the report:

Read 205 page market research report, "Complementary And Alternative Medicine For Anti Aging & Longevity Market Size, Share & Trends Analysis Report By Intervention (Botanicals, Mind Healing), By Customer, By Region, And Segment Forecasts, 2021 - 2028", by Grand View Research

In the traditional alternative medicine/botanicals intervention segment, Ayurveda led the market in 2020 as cosmetic market players are involved in the R&D of Ayurveda-based anti-aging cosmeceuticals. The mind healing segment is expected to witness steady growth from 2021 to 2028 due to the rising acceptance of meditation and mindfulness in corporate offices. The sensory healing segment is expected to expand at a considerable CAGR over the forecast period due to the increasing popularity in hospitals and clinics. For instance, in October 2021, Spatial, an audio platform, partnered with HealthTune scientific and Catalyst by Wellstar to use sensory healing to reduce stress and anxiety of frontline healthcare workers.

Ayurveda is acknowledged as a medicine in 16 countries including Brazil, Switzerland, Hungary, Nepal, Bahrain, UAE, and Saudi Arabia. Whilst, some regions such as Romania, Hungary, Ontario, and Turkey regulate ayurvedic practices. In the U.K., it is a part of the National Health Policy. Thus, increasing acceptance of ayurvedic medicine is expected to drive the complementary and alternative medicine market to a major extent. In addition, insurance coverage by public and private players is anticipated to fuel market growth.

COVID-19 has become a catalyst for the implementation of CAM therapies in day-to-day life. Owing to the pandemic, online yoga classes witnessed a 25% increase in enrollment level. Similarly, in the COVID-19 pandemic, the demand for yoga equipment accelerated by154%. Key players and governing regulatory bodies are undertaking various strategic initiatives such as regional expansion to develop their presence in the market.

Market Segmentation:

Grand View Research has segmented the global complementary and alternative medicine for anti aging and longevity market on the basis of intervention, customer, and region:

List of Key Players of Complementary And Alternative Medicine For Anti Aging & Longevity Market

Check out more studies related to complementary & alternative medicine, published by Grand View Research:

Browse through Grand View Research's coverage of the Global Pharmaceuticals Industry.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry JamesCorporate Sales Specialist, USAGrand View Research, Inc.Phone: 1-415-349-0058Toll Free: 1-888-202-9519Email: [emailprotected]Web: https://www.grandviewresearch.comFollow Us: LinkedIn| Twitter

SOURCE Grand View Research, Inc.

See the article here:
Complementary And Alternative Medicine For Anti Aging & Longevity Market Size Worth $182.9 Billion By 2028: Grand View Research, Inc. - PRNewswire

Former Melbourne GP cops six-year ban over dodgy child vaccination exemptions – The Age

The tribunal found that, from January through to August 2017, Mr Piesse - who fought at the tribunal to keep referring to himself as a non-registered doctor - created and signed 149 false immunisation exemption certificates for unvaccinated children.

Loading

The tribunal, which handed down its decision in the matter this week, heard families would come from far and wide in Victoria, and even interstate, to get the fake certificates.

Along with handing out the dodgy exemptions, Mr Piesse also completed 177 false Medicare vaccination forms so parents and carers of unvaccinated children could claim benefits from the government to which they were not entitled.

The tribunal heard that Mr Piesse attended a screening of the anti-vaccination film Vaxxed in August 2017 at the Hawthorn Arts Centre, where he told an audience medical practitioners could easily support vaccination exemptions, and he was happy to do them up for parents.

He also spouted views that childhood vaccinations were unsafe. The tribunal heard the medical exemptions he handed out said children were exempt from getting a jab until vaccines [were] proven safe by controlled clinical studies.

The board also alleged Mr Piesse did not cooperate with inquiries into his conduct, and misused his status as a medical practitioner.

The former GP, who has not practised since his registration was suspended by the board in 2017, accepted liability for all the allegations against him.

Tribunal members Jonathan Smithers, Robyn Mason, and Laurie Warfe noted his acceptance was grudging, and heavily influenced by personal health considerations.

They decided to disqualify Mr Piesse from applying for registration for six years - until January 24, 2028 - and banned him from using the title doctor until he was, if ever, registered again.

The Morning Edition newsletter is our guide to the days most important and interesting stories, analysis and insights. Sign up here.

Link:
Former Melbourne GP cops six-year ban over dodgy child vaccination exemptions - The Age

Shirley Tilghman wins award for ‘exemplary contributions to the genetics community and society’ – Princeton University

The Genetics Society of America (GSA)selected former Princeton University President Shirley M. Tilghman as the 2022 winner of the George W. Beadle Award for outstanding contributions to the community of genetics researchers.

The award citation lauded Tilghman's "exemplary contributions to the genetics community and society with service on the National Advisory Council for the Human Genome Project Initiative and advocacy for transparent, equitable policies, openness in data sharing and publicly available databases, and sustainable funding policies. The award also recognizes pioneering contributions to mammalian imprinting."

I am deeply grateful to the Genetics Society of America, and my colleagues who nominated me for this wonderful honor, said Tilghman, who is an emerita professor of molecular biology and public affairs in addition to having served as University president from 2001 to 2013. Having an award named after one of the 20thcenturys greatest geneticists is truly meaningful to me.

A native of Canada, Tilghman received her Honors B.Sc. in chemistry from Queens University in Kingston, Ontario, in 1968. After two years of secondary school teaching in Sierra Leone, West Africa, she obtained her Ph.D. in biochemistry from Temple University in Philadelphia.

Tilghman came to Princeton in 1986 as the Howard A. Prior Professor of the Life Sciences. In 1998, she became the founding director of Princetons Lewis-Sigler Institute for Integrative Genomics. She was a member of the National Research Councils committee that set the blueprint for the U.S. effort in the Human Genome Project, as well as one of the founding members of the National Advisory Council of the Human Genome Project for the National Institutes of Health.

She is renowned not only for her pioneering research, but for her national leadership on behalf of women in science and for promoting efforts to make the early careers of young scientists as meaningful and productive as possible.

Her other awards and honors include being named a Howard Hughes Medical Institute Investigator in 1988, winning the LOral-UNESCO Award for Women in Science in 2002, receiving the Lifetime Achievement Award from the Society for Developmental Biology in 2003 and receiving the GSA Medal in 2007. She is a member of the American Philosophical Society, the National Academy of Sciences, the Institute of Medicine and the Royal Society of London.

The Beadle Award is awarded annually to someone who the GSA determines has contributed to the genetics community beyond an exemplary research career, for example by creating an invaluable technique or tool, helping the community adopt a model system, being a voice for the community in public or political forums, or maintaining active leadership roles. GSA established the award in 1999 in honor of George W. Beadle (1903-1989), an outstanding scientist and a respected academic and public servant who won the 1958 Nobel Prize in Physiology or Medicine.

Tilghman and the recipients of the GSA's other awards will present their work in a lecture series to be held online during 2022.

See the rest here:
Shirley Tilghman wins award for 'exemplary contributions to the genetics community and society' - Princeton University

How Columbus health care pros are faring in yet another COVID year therapy dogs help – Columbus CEO

Laura Newpoff| For Columbus CEO

At the beginning of COVID-19, employees at Ohio State University Wexner Medical Center had a gung-ho attitude about being on the front-line of the health crisis. They banded together to bring new units online, increase bed capacity and adopt new treatments. They were running on adrenaline and, even amid the grimmest of outcomes theyd see each day, there was a sense of excitement because they had the chance to save peoples lives.

Nearly two years later, doctors, nurses, respiratory therapists, and even the people who clean the hospital rooms, are over it, says Beth Steinberg, staff training and development, health and well-being. The adrenaline that fueled these health care workers in early 2020 has been replaced with exhaustion from working 16-hour shifts, dealing with people who refuse to wear masks or think COVID isnt real and having to assume the dual role of caregiver and chaplain too often. Add in the political tension and racial unrest that occurred alongside the pandemic in 2020 and the situation became combustible. Many staff members reached a breaking point and some even quit.

Stay up to date with Columbus dynamic business scene: Subscribe to CEO's weekly newsletter, Insider

Steinberg, who has worked as a bedside nurse while raising kids and going to graduate school, knew these caregivers needed support. She was part of a multi-disciplinary senior leadership team that came together to create an employee well-being working group that launched a variety of programs, from chair massages and spiritual care to the deployment of small live string orchestras.

The start of the pandemic also created an opportunity for Steinberg and her colleague Mary Justice to roll out the Buckeye Paws program, which had been in progress since the middle of 2019. The program brings in therapy dogs to provide comfort and emotional support to patient care staff, faculty and students. Steinbergs yellow Labrador retriever Brienne, in fact, is one of the original team members.

Related: Buckeye Paws Program helps Wexner healthcare workers de-stress

This program offers people brief periods of relief from the reality they are facing, Steinberg says. Weve used the dogs for rounds to go and give staff the opportunity to connect with a non-judgmental, highly trained therapy dog. They can talk, pet or cry with the dog, which often happens.

Buckeye Paws resides within the medical centers Stress, Trauma And Resilience (STAR) Program. That program has facilitated small groups of employees gathering with counselors to talk about their experiences during COVID, and a dog can be there as a calming presence. The dogs of Buckeye Paws are certified through the Alliance of Therapy Dogs, and the program follows its guidelines as well as strict medical center policy.

Employees also have been able to benefit from Director of Integrative Medicine Maryanna Klatts Mindfulness in Motion program, which has been integrated into the hospital. In response to the pandemic, Klatt and Steinberg worked together to create 30 short videos with mindfulness techniques for hospital employees. To date, theyve received 32,000 views.

Buckeye Paws and the various programs tied to employee well-being are examples of how health systems across central Ohio have made it a priority to take care of their caregivers during COVID-19. Employee well-being was well-planned, well-orchestrated and it was strategic, Klatt says.

Mount Carmel Health System has a four-pronged approach to employee well-being, which has been adjusted to accommodate needs specific to the pandemic.

Live Your Whole Life is a whole-person-centered program that provides tools and resources related to mental, emotional and spiritual well-being. It includes a collaboration with CareBridge for year-round, around-the-clock counseling.

The colleague care multidisciplinary program brings two peers together who become part of a resilience rounding program. For example, Brian Pierson, the systems vice president of community health and well-being, is a critical care nurse who is paired with Christie Santa-Emma, a licensed social worker. They developed a relationship with the intensive care unit at Mount Carmel East where they participate in rounding cadences to gather information about the challenges employees are facing and to provide information about health and wellness topics. On the first nights round, Pierson and Santa-Emma came into contact with 76 employees, only one of whom was getting enough sleep each night. That led to classes being developed around sleep hygiene.

A healthy living program offers short retreats virtually or in person with licensed psychotherapists to help employees manage the stress and trauma they face each day. And a critical incident stress management program deploys facilitators to help employees who have experienced a trauma at work, such as the death of a patient or colleague.

Pierson says while there have been periods where the number of COVID hospitalizations have declined, health care workers still experience an enormous amount of stress related to the pandemic. So many people who have suffered from severe COVID have a number of comorbidities that have been exacerbated by the disease, he says. When it looks like the ICU numbers are declining, the hospital often is still dealing with these patients who have other problems that have been made worse by COVID. Its an extra stressor for front-line colleagues.

Central Ohio Primary Care leaders also mobilized to support employees during the health crisis. It rolled out a free subscription to DoorDashs DashPass because of COVID and is keeping that in place in 2022. Initiatives that were started that continue today include: a free subscription to Care.com and a resources page to help with childcare options, education, physical activity and nutrition ideas and work-from-home and mental health resources for kids and parents. Free identity theft protection services, an employee share program among practices and discounted and free resources for things like gas, health classes and emotional well-being services also continue to be offered.

COPC also provides employees a variety of mental health resources, including apps that help reduce stress and track physical activity along with educational sessions on self-care. A new employee recognition program was launched alongside a campaign to recognize colleagues for acts of kindness. Hiring COVID screeners and creating an upskill training program also have helped the practices operate more efficiently. Employees got a $1,000 bonus in 2020 and those who have been vaccinated this year also have received $1,000.

Dr. Bill Wulf, COPCs CEO, says health care workers have faced a unique circumstance since the pandemic began. The health crisis has made the home environment more stressful and employees in many other professions can find some peace and quiet when they go to work. Thats not the case in health care. Our young physicians and staff saw an inordinate number of patients die without their families, Wulf says. The stress of this pandemic will take many years to remedy.

Laura Newpoff is a freelance writer.

View post:
How Columbus health care pros are faring in yet another COVID year therapy dogs help - Columbus CEO

7000 Studies Confirm that Turmeric Can Change Your Life: Here Are 7 Amazing Ways to Use It – – Woman’s Era

These days, turmeric is a standout amongst the most prominent flavors utilized all through the world. What you might not have known is that it has been utilized for its therapeutic properties for more than many years. Also, its recuperating potential has been sponsored up by 7000 investigations done in various parts of the world.

In Ayurvedic prescription, it has been utilized for 2 centuries and it is known for its powerful blood purging attributes and healers utilized it when lords were harmed. In any case, it took any longer period for Western drug to incorporate turmeric to medicines. In particular, in the U.S., this stunning flavor has been utilized over the most recent 3 decades as it were.

As indicated by the legend about turmeric, when child Jesus was conceived, the Wise Men from the East brought him gold, frankincense, and myrrh. Many individuals trust that the gold really represents a generally utilized zest of that time, i.e. turmeric. Other than being referenced in the Bible, there are Chinese records of turmeric utilize more established than 2000 years.

Avoids malignant growth:As per specialists from UCLA, curcumin, the fundamental segment of turmeric, can hinder a catalyst which is known to support the development of neck and head disease. Besides, another free lab situated in Maryland evaluated the outcomes and inferred that curcumin obliterated the destructive compounds in the mouths of the patients, which kept the development of threatening cells.

It has antioxidative forces:As indicated by the University of Marylands Medical Center, the powerful cancer prevention agent attributes of turmeric can fend off free radicals. Despite the fact that extra research is required, a ton of studies bring up that curcumin might have the capacity to avoid and treat prostate, colon, and skin malignancy.

It has mitigating properties: As indicated by the restorative executive of the Arizona Center for Integrative Medicine, Randy J. Horwitz, turmeric is a standout amongst other calming specialists and he likewise included that one examination done in 2006 demonstrated that turmeric counteracted rheumatoid joint pain in guinea pigs.

Further on, other research shows that curcumin may lighten uveitis side effects like long haul irritation in the center ear and that turmeric can better the working of the kidneys in patients with aroused kidneys.

Eases osteoarthritis:Turmeric flavor can be of incredible guide in reducing the side effects of a joint pain. In particular, an exploration calls attention to that turmeric separate effectively brought down the torment and distress caused by osteoarthritis.

Treats acid reflux and heartburn:Curcumin triggers the generation of bile which helps the assimilation procedure. As indicated by research, this zest can mitigate furious stomach, gas, and swelling. It can likewise anticipate IBS in solid people.

Coronary illness:A few examinations demonstrate that curcumin can anticipate stores of plaque that may obstruct the corridors and cause heart assaults and stroke.

Counteracts diabetes:A few examinations stress that taking turmeric once a day can avoid prediabetes.

Betters the emotional well-being:Since it can improve the psychological concentration and clearness with its neuro attributes, turmeric can be exceptionally compelling in treating epilepsy, Alzheimers, discouragement, and so forth.

The most effective method to Use Turmeric on a Daily Basis

Include one tsp of turmeric flavor to one measure of kefir.

You will require:

Arrangement:Squeeze the lemon and blend it with the salt and turmeric.

You will require:

Arrangement:Stew the soup and the turmeric for 15 minutes and afterward strain it into a legitimate compartment. Add some dark pepper to build the bioavailability of turmeric.

You will require:

Readiness:Heat up the water and afterward include the turmeric and abandon it to stew for 5 minutes. At that point, expel it from the stove and strain it. Include whatever remains of the fixings and mix well. Appreciate!

You will require:

Arrangement:Put the fixings in a pot and stew them for a moment.

Dont hesitate to add turmeric to your fried eggs for breakfast.

You will require:

Planning:Blend every one of the fixings in a blender for a couple of minutes and after that move the blend into a glass. Appreciate!

Originally posted here:
7000 Studies Confirm that Turmeric Can Change Your Life: Here Are 7 Amazing Ways to Use It - - Woman's Era

KU, KU Medical Center faculty named recipients of Higuchi-KU Endowment Research Achievement Awards | The University of Kansas – KU Today

LAWRENCE Four University of Kansas faculty members on the Lawrence and Medical Center campuses are this years recipients of the Higuchi-KU Endowment Research Achievement Awards, the state higher education systems most prestigious recognition for scholarly excellence.

The annual awards are given in four categories of scholarly and creative achievement. This years honorees:

The four will be recognized at a ceremony this spring along with recipients of other major KU research awards.

This is the 40th annual presentation of the Higuchi awards, established in 1981 by Takeru Higuchi, a distinguished professor at KU from 1967 to 1983, and his wife, Aya. The awards recognize exceptional long-term research accomplishments by faculty at Kansas Board of Regents universities. Each honoree receives $10,000 for their ongoing research.

The awards are named for former leaders of KU Endowment who helped recruit Higuchi to KU.

More about this years winners:

Olin Petefish Award in Basic Sciences

John Kelly is a professor of ecology & evolutionary biology who has made contributions to the fields of evolutionary biology, genetics and botany. He is considered an international leader in evolutionary genetics research, exploring how organisms adapt to their environment. The impact of his research extends to agricultural selective breeding, understanding organismal adaption to climate change and human genetics. He also has been on the forefront of developing computational genome sequencing methods to address biological questions.

Kelly and his collaborators have received more than $6 million in external funding from the National Institutes of Health, the National Science Foundation and other institutions. He has published more than 100 peer-reviewed articles and served as secretary for the Society for the Study of Evolution. He earned his doctorate in ecology and evolution from the University of Chicago.

Balfour Jeffrey Award in Humanities & Social Sciences

Beth Bailey, Foundation Distinguished Professor and member of the Department of History, is an internationally renowned historian of the United States military, war and society, and the history of gender and sexuality. She is the founding director of KU's Center for Military, War, and Society Studies, which brings together scholars, military leaders, government officials and students to discuss issues relevant to the military, war and more.

In the past year, she has received an Andrew Carnegie Fellowship and was named one of 24 National Endowment for the Humanities Public Scholars for her research on race and the U.S. Army. She was elected to the Society of American Historians in 2017, and the secretary of the Army appointed her to the Department of the Armys Historical Advisory Committee.

Baileys vast publication record includes journal articles, book chapters and books on a variety of subjects, including the history of gender and sexuality, U.S. military history and social history. She holds a doctorate and masters degree in American history from the University of Chicago.

Irvin Youngberg Award in Applied Sciences

Steven Soper is a Foundation Distinguished Professor of chemistry, mechanical engineering and bioengineering as well as an adjust professor of cancer biology and member of The University of Kansas Cancer Center. A world leader in bioanalytical chemistry, he researches biological macromolecules including DNA, RNA and proteins to develop new tools for medical diagnostics and discovery.

Soper directs the NIH-funded and multi-institutional Center of BioModular Multi-Scale Systems for Precision Medicine based at KU. The center coalesces scientists, clinicians and biomedical engineers to design, manufacture and deliver biomedical tools for detecting and managing disease. For example, the center developed an at-home rapid COVID-19 test that is now going to market.

Soper has founded two companies, BioFluidica and Sunflower Genomics, to translate his research into commercial products. He received a doctorate in bioanalytical chemistry from KU.

Dolph Simons Award in Biomedical Sciences

Dr. Russell Swerdlow is a professor in the Department of Neurology at KU Medical Center, with secondary appointments in molecular & integrative physiology and biochemistry & molecular biology. Swerdlow directs KUs Alzheimer's Disease Research Center, and his contributions have helped make KU a world leader in Alzheimers care and research.

His work has defined a role for mitochondrial dysfunction in late-onset neurodegenerative diseases, including Alzheimers. He proposed a hypothesis for the cause of the disease, the sporadic Alzheimers disease mitochondrial cascade hypothesis, which has steadily gained traction for over a decade. His research also has identified potential therapeutics for the disease.

Swerdlow received his doctor of medicine from New York University.

The award funds are managed by KU Endowment, the independent, nonprofit organization serving as the official fundraising and fund-management organization for KU. Founded in 1891, KU Endowment was the first foundation of its kind at a U.S. public university.

See the original post here:
KU, KU Medical Center faculty named recipients of Higuchi-KU Endowment Research Achievement Awards | The University of Kansas - KU Today

Psychedelic and Plant Medicines: A Portal to Transformative Realms of Possibility – Non Profit News – Nonprofit Quarterly

OUR STORIES OUR VISIONS SERIES #10 BY AMIR KHADAR/WWW.AMIRKHADAR.COM

Click here to download this article as it appears in the magazine, with accompanying artwork.

This article is from the Winter 2021 issue of the Nonprofit Quarterly, We Thrive: Health for Justice, Justice for Health.

If anything has the potential to alter the grievous state of mental health and well-being and move us toward visionary, transformative and liberatory realms of possibility, it is the psychedelic renaissance we are on the cusp of today.1 The prospects for individual mental health and the transmutation of trauma alone are encouraging, but it is the potential for rebirth that keeps me engaged in and inspired by this work: the promise of our ego dissolving into its rightful place as steward of the soul; increased awareness of both our interconnection to one another and this planet, and thus the emergence of a more responsible, respectful, and reciprocal society; and expanded access to the creativity needed for systems change and eco-innovation. Psychedelic and plant medicines, some of which have been used in ceremonial contexts for thousands of years to transform consciousness, may be one of the only viable tools we have available that can properly awaken us from the illusions we currently occupy, keeping us stuck in the patriarchal, capitalistic, supremacist paradigms that govern our experience of life on this planet. Understanding and learning from plant-based or synthetic psychedelics is a quest to understand consciousness, the mystery of the universe, and our place within it.

As a forthright advocate for the safe use of psychedelics, and psychedelic psychotherapy in particular, my hope is that we can reintroduce these healing modalities to society, with great caremaking sure to avoid the usual profit-driven pitfalls that ravage our mental healthcare system and make wellness accessible to few. For health justice to succeed, we need to heal the past and step intentionally and attentively into new models and standards of care. This medicine space, like most other spaces that humans engage with, is ripe with opportunities for exploitation, misuse, and abuse, and it would be remiss not to address this fact.2 The greatest harm caused rests on the shoulders of the policy-makers who relegated this work to the shadows in the first place, criminalizing the use of psychedelics, incarcerating countless humans (mostly people of color), suppressing research, peddling misinformation, and all but guaranteeing that much of this work would be conducted in secret, where unsafe usage and abuses of power run amok.3 Few people question that the war on drugs has been a disaster of epic proportions, and it is our collective opportunity to encourage decriminalization, medicalization, and legalization of psychedelic and plant medicines, so that appropriate safeguards can be established.4

It is important for me to name at the outset that I am not a member of one of the many Indigenous communities that hold great wisdom on the topic of plant medicine; nor am I one of the experienced and revolutionary psychedelic guides who have been courageously practicing this form of healing underground for the last half century.5 I am a white-bodied, cisgender, transpersonal psychotherapist and trauma specialist with extensive experience in community and private mental-health practice. Though I was once optimistic about our human potential to survive adverse experiences and thrive beyond them, my years of treating trauma within the confines of a limited and limiting mental healthcare systemcombined with the increasing collective distress brought on by political unrest, gross inequality, climate crisis, and pandemic diseasehave challenged my confidence. Despite mounting frustration, I hold out hope; and my commitment to finding creative solutions to the problems I see plaguing us has led me to psychedelic psychotherapy.

I began my training with the Multidisciplinary Association for Psychedelic Studies (MAPS) in MDMA-assisted therapy for post-traumatic stress disorder (PTSD), in 2018. MAPS, a pioneer in the field of psychedelic psychotherapy, conducts extensive research in the United States, Canada, and Israel; is engaged in drug policy reform; trains diverse cohorts of therapists; prioritizes health equity; and privileges public benefit over profit. Most important, MAPS is steadily moving the work forward using evidence-based research to establish the safest and most ethical legal container possible for working with expanded states of consciousness.6 My training, the final elements of which require FDA approval, opened the door to a world of possibility and hope once diminished by the mental health system.7 I have spent the three years since my initial training with MAPS ended continuing my studies with various educators and elders in the fieldworking to integrate and balance Indigenous wisdoms with the latest science, and learning and practicing in legal contexts to develop my skills as a psychedelic guide.

While there are a variety of molecules in the psychedelic category currently being researched in the laboratory, including but not limited to MDMA, Ibogaine, Ketamine, and 5-MeO-DMT, the psilocybin mushroom beautifully illuminates the potency of this work. A wise teacher of mine describes the various principles of the mushroom as a mirror. Mushrooms are the fruit of a large subterranean organism, their underground growth reflecting the unconscious shadow material we are unearthing each time we ingest their medicine. This organism and its underground mycelium, a network that connects all plant life and serves to transfer nutrients and minerals among them, reflects and teaches the interconnectivity of all living things and the idea that the exchange of love, care, and mutual regard are necessary for our health, well-being, and survival. Mushrooms are ephemeralthey fruit and die off quickly, reflecting and teaching the brevity of life and the impermanent nature of all things. They communicate to us the importance of letting go and embracing cycles of death and rebirth. Mushrooms are composters: filterers of toxicity that discard waste, they transform one thing into another in much the same way we in the healing professions work to transmute trauma and support the flow of grief as a means to make space for the integration of a renewed sense of meaning and purpose. While the mushroom provides us with plenty of useful metaphors, each psychedelic and plant medicine has its own unique spirit, and the molecules most aligned for ones growth can only be determined by oneself or with the support of a therapist or experienced guide.

Psychedelics, known for their mind-expanding and often heart-opening qualities, create opportunities for us to zoom out and witness our humanity from a wider perspectivean otherwise tall order for a person contracted by depression, anxiety, and/or traumatic injury. Furthermore, psychedelic medicines can induce powerful mystical experiences or glimpses into realms of the unknown, the contents of which have the potential to initiate the reorganization of our perception of reality and liberate us from the injuries that confine us.

The singular act of ingesting psychedelics, however, is not where the real magic unfolds. It is in several other important elements of this work that the conditions for transformation are created: Intention, preparation, set and setting, and integration are necessary agents when working with psychedelic medicines for the purpose of healing. Without these cornerstones in place, the experience lacks the container to yield truly meaningful results, and, in some cases, harm can result.

I once read the words Be careful where you are headed, or you may end up where youre going8a humorous but cautionary reminder of the importance of establishing an intention when doing any kind of healing work. We must first know why it is we are taking these medicineswhat it is we seek to heal, change, or understand about ourselves, our relationships, the universe. Intention aligns the journey with purpose and grounds the journeyer. Journeying with intention almost always leads to insights directly or symbolically related to the intention itself, and can serve as a powerful anchor point to return to when traversing difficult terrain and when engaged in the integration process.

Preparation is the practice of preparing the journeyer (client) and establishing trust between journeyer and guide (therapist). The guide starts with a thorough intake and client history, assessing for potential contraindications. Once it is determined that a client can safely move forward with the journey, the clients mental, emotional, physical, spiritual, and environmental situation is explored, and the guide shares details of what to expect within the journey space. It is important that the client be of sound mind and have sufficient ego strength to enter an expanded state. They must be capable of creating space inside themself for the journey and for the process that follows.

Set and Setting refers to both the mindset of the journeyer and the container within which the journey itself takes place. Insofar as mindset is concerned, the journeyer must be prepared to surrender to the experience. While nervousness is inevitable, excessive fear and anxiety about the journey itself may interfere with a clients capacity to loosen their grip and give way to the process. If conditions have changed and an acute crisis or life challenge has emerged between the prep sessions and the intended journey date, a persons mindset may be compromised. Ensuring the client is stable and resourced enough to enter the journey space is essential, and will be evaluated in preparatory sessions and on the day of the journey.

It is the guides responsibility to establish a safe container and to communicate what that entails. The therapist or therapists (the MAPS protocol calls for two) communicate standard rules and steps for the journey, prepare music, control environment, temperature, and other such details, and monitor client needs throughout the process. Most important, the guide will have two feet in this dimension of reality, creating a safe space for the client to surrender to the effects of the medicine and retreat into the unconscious. If the therapist or client emerges from a particular lineage/culture and/or wishes to include a ceremonial- or ritual-based practice in the session, space is made to honor whatever spiritual or earth-based wisdom tradition that calls to be honored.

In addition to establishing trust with the guide and being of sound mind, the environment is an exceptionally important aspect of creating a safe container for the work taking place. Journey spaces and treatment rooms should be tranquil, calm, and invitingsafe sanctuaries with limited outside interference. Natural environments can also provide a deeply healing and supportive cocoon for this work. In many cases, access to nature is limited, and some studies are incorporating digital content as a way of simulating an experience of the natural world. According to renowned cinematographer and Fantastic Fungi director Louie Schwartzberg, a current study being conducted at the Pacific Neuroscience Institute on the use of psilocybin for alcohol abuse is incorporating elements of his Moving Art nature cinematography in sessions with subjects.9

And lastly, there is integration. By far the most important aspect of this work, integration is the key to ensuring that a psychedelic journey leads to meaningful change. Integration is the process of both embodying and actionizing the insights derived from a journey. It is one thing to adventure off to a supernatural world that defies the boundaries of this dimension of reality, and quite another to make use of that experience in a way that enhances the quality of our lives and benefits those around us.

Because psychedelic experiences often reveal information symbolically and have the potential to open difficult doors, its important that a competent and well-trained therapist provide a solid container of love and compassion as the client works to interpret the content of their journey after the fact and heal whatever material may have surfaced in the journey space.

As a therapist, I know all too well how slow the healing process can be, especially as we contend with increasingly complex trauma and an overmedicated and underresourced population. Psychedelic therapy cuts through many of the interpersonal and neurobiological self-protective mechanisms established in response to injurious experience. Those default modes are barriers to our healing and often need a powerful interruption to initiate change.10 Inducing a non-ordinary experience can speed the healing and life transformation process along, producing insights within hours that might otherwise take years to access in traditional psychotherapeutic models. In that way, a journey is like a wormhole, or passage through space and time. The insights and experiences clients emerge with then require attentive exploration in service of organization and integration.11 Integration grounds us back into our bodies and physicalizes the spiritual or ethereal wisdom we touch. Without integration, a psychedelic experience is just that: an experienceand the degree to which it is useful is up for debate. Integrating a psychedelic experience with psychotherapy or other mindfulness-based integrative modalities helps us to lay new cable and create healthier connections in the brain and extended nervous system, and in our relationships.12 This work, if done intentionally and integrated effectively, is extremely powerful and fast acting. It can liberate a person from pain and restore vitality, creativity, and a sense of meaning.13

***

As this work travels from its Indigenous birthplaces to the Wild West underground to the laboratory to the therapy room, it continues to evolveand so, too, does our understanding of how to best be in a responsible and respectful relationship with these modalities. Recognition that traditional mental health models continue to fail our most vulnerable populations helps to build momentum and support for alternative approaches like psychedelic psychotherapy. Many questions remain unanswered around how this work can be conducted safely, cost- effectively, and at a scale that provides the greatest benefit for all. However, with the second phase 3 clinical trial for MDMA-assisted psychotherapy in process (MAPP1 is complete; the second trial, MAPP2, is underway) and studies being conducted all over the world at leading research institutions, it is only a matter of time before this is an accessible treatment option and self-actualization tool.14 Psychedelic medicines will not work for everyone, but we can do better where whole health is concerned. We have all the necessary instruments at our disposal for a radical shift in human consciousness and the cultivation of a more harmonious human family. I continue to look to organizations like MAPS that are learning from the past and leading the way with intention to a future where visions of equitable access to mass mental health are realized, and health justice prevails.

Andrea Anderson, LSD May Chip Away at the Brains Sense of Self Network, Scientific American, April 13, 2016, http://www.scientificamerican.com/article/lsd-may-chip-away-at-the-brain-s-sense-of-self-network/.

Subscribe to the NPQ newsletter to have our top stories delivered directly to your inbox.

By signing up, you agree to our privacy policy and terms of use, and to receive messages from NPQ and our partners.

Robin L. Carhart-Harris et al., Psilocybin with psychological support for treatment-resistant depression: six- month follow-up, Psycopharmacology 235, no. 2 (February 2018): 399408.

Robin L. Carhart-Harris et al., The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs, Frontiers in Human Neuroscience (February 2014).

Daniel Collerton, Psychotherapy and brain plasticity, Frontiers in Psychology (September 2013).

James Fadiman, The Psychedelic Explorers Guide: Safe, Therapeutic, and Sacred Journeys (Rochester, VT: Park Street Press, 2011).

Ingmar Gorman et al., Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice, Frontiers in Psychology (March 2021).

Stanislav Grof, The Way of the Psychonaut, Vols. 1 and 2 (Santa Cruz, CA: MAPS, 2019).

Carl L. Hart, Drug Use for Grown-Ups: Chasing Liberty in the Land of Fear (New York: Penguin Press, 2021). Albert Hofman, LSD: My Problem Child (New York: McGraw Hill, 1980; repr., Oxford, UK: Oxford University Press, 2019).

Voices of Esalen: Psychedelic Integration, Pt. 3: Rick Doblin on MAPS, MDMA, Esalen, and PTSD, Voices of Esalen, podcast, July 19, 2019, maps.org/2019/07/19/voices-of-esalen-psychedelic-integration-pt-3- rick-doblin-on-maps-mdma-esalen-and-ptsd/.

Ralph Metzner, Opening to Inner Light: The Transformation of Human Nature and Consciousness (Los Angeles: Jeremy P. Tarcher, 1986).

Michael Pollan, How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence (New York: Penguin Press, 2018).

Michael Pollan, This Is Your Mind on Plants (New York: Penguin Press, 2021).

Tim Read and Maria Papaspyrou, eds., Psychedelics and Psychotherapy: The Healing Potential of Expanded States (Rochester, VT: Park Street Press, 2021).

Tom Schroder, Acid Test: LSD, Ecstasy, and the Power to Heal (New York: Blue Rider Press, 2014).

Ben Sessa, The Psychedelic Renaissance: Reassessing the Role of Psychedelic Drugs in 21st Century Psychiatry and Society (London: Muswell Hill Press, 2012).

Daniel J. Siegel, Aware: The Science and Practice of PresenceThe Groundbreaking Meditation Practice

(New York: TarcherPerigee, 2018).

Daniel J. Siegel, Pocket Guide to Interpersonal Neurobiology: An Integrative Handbook of the Mind (New York: W. W. Norton & Company, 2012).

Bessel A. van der Kolk, Posttraumatic Therapy in the Age of Neuroscience, Psychoanalytic Dialogues: The International Journal of Relational Perspectives 12, no. 3 (2002): 38192.

Bessel van der Kolk, The Body Keeps the Score: Brain, Mind, and Body in the Healing of Trauma (New York: Viking Press, 2014).

Roger Walsh and Charles S. Grob, eds., Higher Wisdom: Eminent Elders Explore the Continuing Impact of Psychedelics (Albany: State University of New York Press, 2005).

Ayelet Waldman, A Really Good Day: How Microdosing Made a Mega Difference in My Mood, My Marriage, and My Life (New York: Knopf, 2017).

See the original post here:
Psychedelic and Plant Medicines: A Portal to Transformative Realms of Possibility - Non Profit News - Nonprofit Quarterly

The #1 Worst Food for Arthritis, Says Dietitian Eat This Not That – Eat This, Not That

Additional reporting by Leo Andreoli.

Picking out the #1 worst food to eat if you have arthritis isn't easy, and that's because an arthritis diagnosis comes with a lot of variables.

For one, what makes one person's joint pain worse may be totally different from what exacerbates another's, according to Heidi Turner, MS, RDN, CD, an integrative registered dietitian nutritionist with Food Logic, who specializes in autoimmune and inflammatory conditions.

Secondly, there are various types of arthritis, each of which may be made worse by something different in the diet. Four common forms of arthritis are osteoarthritis, which is a wearing down of the cartilage in the joints due to aging; rheumatoid arthritis (RA), an autoimmune disease in which the immune system attacks healthy cells and causes inflammation typically in the hands, wrists, and knees; gout, which usually affects one joint at a time, often starting with the big toe, and ankylosing spondylitis; or ankylosing spondylitis (AS), which reduces the flexibility of the spine.

RELATED: Telltale Signs You Have Arthritis

"Everybody's different; one person with osteoarthritis can eat a food (and feel fine) while another can have a really bad reaction to it," says Turner.

With that in mind, to find the #1 worst food for arthritis, the solution is to try an "elimination diet," that is, eliminating foods to identify those that make you feel better when you stop eating them. Read on to learn more about how to try an elimination diet to pinpoint the foods that worsen arthritis symptoms as well as the most likely culprits, and for more on how to eat healthy, don't miss The #1 Best Juice to Drive Every Day, Says Science.

While an elimination diet will help you find the worst foods for your arthritis, Turner says processed and high-sugar foodsare generally the worst foods for sufferers of any type of arthritis for the same reasons they are harmful to your overall health. "Foods that contain a lot of chemicals and preservatives, high-starch foods, sugars, highly-processed grains, things like that will encourage inflammation and are what you want to get out of your diet first and replace with whole foods," she says.

Sign up for our newsletter!

New research from Mayo Clinic's Center for Individualized Medicine suggests a connection between an unhealthy gut microbiome and rheumatoid arthritis. The trillions of bacteria in the gastrointestinal tract are impacted by what you eat, and an imbalance of healthy and unhealthy bacteria may make RA symptoms worse, according to the study.

What are those foods that cause an unhealthy gut? Inflammatory foods like saturated and trans fats, fried foods, corn oil, and baked goods. "If you're working with a lot of gut issues, then you might try to take out those known inflammatory foods, including gluten and dairy," says Turner.

Some people with arthritis find that eating tomatoes, eggplant, potatoes, and peppers trigger arthritic swelling and stiffness. "Eating nightshade plants can irritate the joints; I see that quite a lot in my practice," says Turner.

The inflammatory reaction may be due to a buildup of a bitter-tasting chemical found in nightshade plants called solanine, according to the Cleveland Clinic. However, giving up nightshades come with a downside: you'd miss out on some highly nutritious foods, the Cleveland Clinic notes.

The form of arthritis known as gout occurs when there is too much uric acid in the body and crystals of uric acid accumulate in the joints, causing swelling and pain. Uric acid is the result of the breakdown of chemical compounds in certain foods called purines. "Gout is its own little beast," says Turner. The worst foods to eat if you have gout are "foods high in purines like organ meats, alcohol (especially beer), sardines, and sweet beverages like soda and juices with high fructose corn syrup," she says. Even certain vegetables, like cauliflower and asparagus, are higher in purines than others and may cause inflammation in a joint.

Because foods can affect people so differently, eliminating certain inflammatory foods and monitoring how your body reacts may be the best way to identify those that worsen your arthritis symptoms, says Turner. Other tactics to try, she says, are adopting a paleo diet or Mediterranean-style diet. Both include fruits, vegetables, nuts, seeds, lean meats, and fish and shun added sugars and processed grains. To learn more about the health benefits of this style of eating, read What Happens to Your Body on the Mediterranean Diet.

Go here to read the rest:
The #1 Worst Food for Arthritis, Says Dietitian Eat This Not That - Eat This, Not That

NIH Guidelines | OSP – National Institutes of Health

On August 16, 2018, the NIH Director issued a statement describing a proposal to streamline the federal framework for oversight of gene therapy. This proposal, which was developed in conjunction with the Food and Drug Administration, included amending the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) to eliminate duplicative review and reporting requirements for human gene transfer protocols. The statement also describes NIHs effort to refocus the role of the NIH Recombinant DNA Advisory Committee (RAC) to be closer to its original mandate a transparent forum for science, safety, and ethics of emerging biotechnologies. After a 60-day public comment period, the NIH Guidelines have been updated to reflect these changes and the RAC has been renamed the Novel and Exceptional Technology and Research Advisory Committee (NExTRAC).

The charter of the NExTRAC reflects the shift in focus of the committee while embracing the continuity of this important advisory committee.

Federal Register Notice

Charter of the NExTRAC

NIH Directors Statement

Under the Poliscope Blog

NIH Guide to Grants and Contracts Notice

See original here:
NIH Guidelines | OSP - National Institutes of Health

Health Disparities Research and Biotechnology – JMU – James Madison University

SUMMARY: Simon Anderson (22) combines advanced physical science and competencies necessary to help people of different backgrounds, capacities, and beliefs.

Simon Anderson is building an Independent Scholars major around disparities in health and healthcare that stem from broader issues of diversity, equity, and inclusion. His major emphasizes coursework in biology and the medical humanities. Simon is also pursuing a degree in Biotechnology, with minors in Honors Interdisciplinary Studies and Pre-Medicine. Simon is a prime example of a Biotech student at JMU--passionate, determined, engaged, and innovative, says Dr. Stephanie Stockwell, past director of the Biotechnology program. By combining a wide array of interests and talents, Simon is paving the way for a lifetime of success and positive impact.

Simon is a graduate of South County High School in Fairfax County, Virginia, where he completed a demanding set of AP courses that nurtured his passions for math, biology, and chemistry. He also participated in the Governors School for Medicine and Health Sciences at Virginia Commonwealth University in the summer of 2017. During this program he worked with other students to examine case studies from three perspectives: Person (in-person interviews with the patient), Scientist (lab tests and results), and Community (implications of the ailment for the surrounding people)before splitting into smaller groups and analyzing a case study from all three perspectives simultaneously. In the area I grew up in, sickness and injury were the main reasons people went to the hospital, not for treatments related to opioid abuse, Simon remembers. But I learned that opioid abuse was also becoming a huge problem. Later, at JMU, he learned about the importance of local and county remote access clinics. Its not just in cities where people lack healthcare services, says Simon. If youre in a rural area you may also not have access.

Simon took a Viral Discovery (ISAT 203) course with ISAT professor Dr. Louise Temple in his freshman semester. In that class, Simon had his first real encounter with laboratory research. Viral Discovery is an exploratory experiential science class designed for incoming freshmen. Students learn about the life cycle and ecology of viruses infecting bacteria, collect soil samples, and practice techniques for isolation and purification of viruses from the soil. Dr. Temple is an expert in bacterial pathogenesis and bacterial virus discovery and genomic analysis. Isolated viruses are visualized in her lab using electron microscopy, and the genomic material is isolated and prepared for nucleic acid sequencing. Dr. Temples class built confidence in my ability to assess a problem and come up with solutions in a setting where theres flexible structure and no right answer, Simon recalls. He wanted to keep on with the work he had invested in phages, and so joined Dr. Temples lab. Simon has learned a number of valuable techniques related to DNA isolation and annotation, and is writing a paper about phages.

More recently, Simon enrolled in Cancer Genetics (BIO 477) with Dr. Tim Bloss, associate professor of biology. The course is cross-listed as a graduate-level course (BIO 577). I really enjoyed learning about how cancer develops and progresses, he says. Learning about molecular malfunctions in cancer helps me think about how I might create and test treatments in the future. Simon notes that Dr. Bloss is gifted at explaining genetics to students at both a basic and advanced level.

Simon is also a teaching assistant for JMUs General Chemistry laboratory courses (CHEM 131L and CHEM 132L). The course is designed to acquaint students with basic procedures and techniques encountered in the chemical laboratory. The experiments illustrate these techniques and supplement lectures. Simon gives instruction to students and assists with in-class procedures. He also digitally comments on students lab plans, data, and reports. It was a difficult, hybrid year of lab instruction due to the COVID pandemic. At first professors filmed experiments in the lab themselves, and then trialed virtual lab simulation software. This spring, Simon and other assistants returned to the labs to teach students. Proper use of pipette filler bulbs is one lesson we teach, notes Simon, People seem to have a lot of trouble with them.

Simon joined Independent Scholars to extend and broaden his undergraduate education. He understood that medical schools want to see students prepare themselves with an education in both science and the humanities. Simon found the Medical Humanities minor in the JMU catalog, and realized that he might build a major around it. Simons major is entitled Social Responsibility in Healthcare. It combines physical science and competencies necessary to help people of different backgrounds, capacities, and beliefs.

I wanted to take more classes across a wider range of subjects, says Simon. The Independent Scholars major made it possible to take a bunch of science courses that built a broader base around medical humanities. Simon hopes that the Independent Scholars major will give him exposure to a little bit of everything:biology, chemistry, bioinformatics, sociology, anthropology, psychology, and philosophy. I am just beginning to realize the connections between everything, he says. I want to understand how my research into biology and chemistry intersects with disparities in healthcare and beyond.

Simon says he likes the Independent Scholars approach to learning: I develop my questions, and then look for courses and experiences that can help me answer those questions. I wanted something different, to choose an area of study where the questions arent well established, or the answers known. Simon has written about the complexities of healthcare for the Independent Scholars e-zine on multiple occasions. In his essays, Simon seeks answers to enduring questions: What does it mean to be a doctor in our globalized world? How do institutions treat people of different backgrounds differently? What is healthy, and who gets to decide what healthy is? What are the impacts of structural and institutional prejudices? he asks. Simon is currently studying and writing about how person-oriented perspectives characterized by a holistic approach to patient management that embraces the physical, psychological, and social aspects of health and disease are becoming essential to undergraduate pre-medical education. His essays may be accessed here.

Independent Scholars students complete a culminating capstone project. Simons project has implications for the mitigation of racial disparities in health. He notes that, despite having roughly equal rates of breast cancer as non-Hispanic white women, African-American women are 40% more likely to die from the disease than white women, experience the highest breast cancer mortality of any racial group, and have an increasing rate of incidence of breast cancer. African American women are also more likely to have hormone-dependent breast cancers, which are deadlier than hormone-independent tumors.

Researchers have shown that delivering the protein HES-1 to hormone-dependent breast cancers has the effect of decreasing a nuclear protein called PCNA (found in dividing cells), which inhibits proliferation of the tumor, explains Simon. Were attempting to show that oxidative stress will prompt production of the GFP encoded behind an hlh-29 promoter to increase green fluorescent protein expression in all cells. If Simons project can provide evidence that oxidative stress is capable of increasing cells levels of proteins like HES-1, then they will have also laid the groundwork for potential clinical applications. One such application could be the induction of localized oxidative stress in tumors in an attempt to stall their proliferation, which would provide other therapies with an opportunity to shrink and kill the cancer.

Simon was a member of JMUs Huber Residential Learning Community (RLC) for freshmen in 2018-2019. The Huber RLC (which no longer operates) required two classes, one in each of the students first semesters. These classes focused on how different fields of medicine coexist, and gave a place for analysis and discussion of the social determinants of health. In the second semester, each student was required to volunteer with health- and education-related services in Rockingham County and Harrisonburg. Simon volunteered with the Virginia Personal Responsibility Education Program Innovative Strategies (VPREIS) project through JMUs Institute for Innovation in Health and Human Services (IIHHS). His volunteer work included working through the units of VPREISs Vision of Youa program for teen sexual and social health education, currently being administered to at-risk youth as part of a randomized controlled study in decreasing teen pregnancy in Virginia. Simon also volunteered at the ECHO (Ecumenical Community Helping Others) food pantry in Springfield, Virginia during the COVID-19 pandemic.

In the summer of 2021, Simon participated in a virtual summer research internship with the Pediatric Oncology Branch of the National Cancer Institute. During the experience, he worked on three projects that identified novel potential molecular targets in neuroblastoma, devised assembly schemes for designing new chimeric antigen receptors, and reviewed transcripts, patient data, and trial design documents for new psychological health programs. He also attended daily interactive seminars on many topics, including pediatric bone and neural cancers, cancer predisposition syndromes, lab mouse genetics, translation of basic science into therapies, and patient advocacy. Outside of the POB, he participated in an immunotherapy journal club, and two workshops on health disparities and social injustice in health research.

Simon also nurtures interests in how things are made. He enjoys watching videos about how the Disney and Universal theme parks create their engineered attractions, and builds models of landmarks and machinery from around the world. In the summer of 2019, Simon taught LEGO Robotics classes to young people in the Fairfax Collegiate Summer Program, based in Herndon.

See the rest here:
Health Disparities Research and Biotechnology - JMU - James Madison University

Regional Strategic Analysis of Pharmaceutical and Biotechnology Market during the Forecasted Period 2020-2030 Construction News Portal – Construction…

Prophecy Market Insights recently presented Pharmaceutical and Biotechnology market report which provides reliable and sincere insights related to the various segments and sub-segments of the market. The market study throws light on the various factors that are projected to impact the overall dynamics of the Pharmaceutical and Biotechnology market over the forecast period (2019-2029).

The Pharmaceutical and Biotechnology research study contains 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. This Pharmaceutical and Biotechnology market research report estimates the size of the market concerning the information on key retailer revenues, development of the industry by upstream and downstream, industry progress, key highlights related to companies, along with market segments and application. This study also analyzes the market status, market share, growth rate, sales volume, future trends, market drivers, market restraints, revenue generation, opportunities and challenges, risks and entry barriers, sales channels, and distributors.

Base Year

Estimated Year

Forecast Year

2019

2020

2019-2029

Get Sample Copy of This Report @ https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/881

Global Pharmaceutical and Biotechnology market 2020-2030 in-depth study accumulated to supply latest insights concerning acute options. The report contains different predictions associated with Pharmaceutical and Biotechnology market size, revenue, CAGR, consumption, profit margin, price, and different substantial factors. Along with a detailed manufacturing and production analysis, the report also includes the consumption statistics of the industry to inform about Pharmaceutical and Biotechnology market share. The value and consumption analysis comprised in the report helps businesses in determining which strategy will be most helpful in expanding their Pharmaceutical and Biotechnology market size. Information about Pharmaceutical and Biotechnology market traders and distributors, their contact information, import/export and trade analysis, price analysis and comparison is also provided by the report. In addition, the key company profiles/players related with Pharmaceutical and Biotechnology industry are profiled in the research report.

The Pharmaceutical and Biotechnology market is covered with segment analysis and PEST analysis for the market. PEST analysis provides information on a political, economic, social and technological perspective of the macro-environment from Pharmaceutical and Biotechnology market perspective that helps market players understand the factor which can affect businesss accomplishments and performance-related with the particular market segment.

Segmentation Overview:

By Product Type(Vaccines (Recombinant Vaccines, Conventional Vaccines, Recombinant Enzymes, Cell and Gene Therapies and Other Product Types) and Synthetic Immuno-modulators (Cytokines, Interferones, Interleukins and Tumor Necrosis Factor))

By Therapeutic Application (Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Disease Prevention, Cardiovascular Diseases, Neurological Diseases and Other Diseases)

By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Competitive landscape of the Pharmaceutical and Biotechnology market is given presenting detailed insights into the company profiles including developments such as merges & acquisitions, collaborations, partnerships, new production, expansions, and SWOT analysis.

Pharmaceutical and Biotechnology Market Key Players:

Pfizer

Roche

Johnson-Johnson

Sanofi

Merck, Novartis

Amgen Abbott Laboratories,

Agilent Technologies, Ely Lily

Biogen Scientific

Bio-Rad Laboratories

Danaher, F. Hoffmann-La Roche

Illumina

Merck

PerkinElmer, Qiagen

Thermo Fisher Scientific.

The research scope provides comprehensive market size, and other in-depth market information details such as market growth-supporting factors, restraining factors, trends, opportunities, market risk factors, market competition, product and services, product advancements and up-gradations, regulations overview, strategy analysis, and recent developments for the mentioned forecast period.

The report analyzes various geographical regions like North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa and incorporates clear market definitions, arrangements, producing forms, cost structures, improvement approaches, and plans. Besides, the report provides a key examination of regional market players operating in the specific market and analysis and outcomes related to the target market for more than 20 countries.

Download PDF Brochure for report overview @ https://www.prophecymarketinsights.com/market_insight/Insight/request-pdf/881

The report responds to significant inquires while working on Global Pharmaceutical and Biotechnology Market. Some important Questions Answered in Pharmaceutical and Biotechnology Market Report are:

Get In-depth TOC @ https://www.prophecymarketinsights.com/market_insight/Global-Pharmaceutical-and-Biotechnology-Market-881

Contact Us:

Mr. Alex (Sales Manager)

Prophecy Market Insights

Phone: +1 860 531 2701

Email: [emailprotected]

See the rest here:
Regional Strategic Analysis of Pharmaceutical and Biotechnology Market during the Forecasted Period 2020-2030 Construction News Portal - Construction...

Chromatography Resin for Pharmaceuticals & Biotechnology Application Market 2022 Size, Share, Revenue, Growth Opportunities, Trends and Demand by…

The latest research report provides a complete assessment of the Chromatography Resin for Pharmaceuticals & Biotechnology Application Market for the forecast year 2022-2031, which is beneficial for companies regardless of their size and revenue. This Survey report covers the major market insights and industry approach towards COVID-19 (Omicron) in the upcoming years. The Chromatography Resin for Pharmaceuticals & Biotechnology Application Market report presents data and information on the development of the investment structure, technological improvements, market trends and developments, capabilities, and comprehensive information on the key players of the Chromatography Resin for Pharmaceuticals & Biotechnology Application Market. The worldwide market strategies undertaken, with respect to the current and future scenario of the industry, have also been listed in the study.

The report begins with a brief presentation and overview of the Chromatography Resin for Pharmaceuticals & Biotechnology Application Market, about the current market landscape, market trends, major market players, product type, application, and region. It also includes the impact of COVID-19 (Omicron) on the global Chromatography Resin for Pharmaceuticals & Biotechnology Application Market trends, future forecasts, growth opportunities, end-user industries, and market players. It also provides historical data, current market scenario and future insights on Chromatography Resin for Pharmaceuticals & Biotechnology Application Market. This study provides a comprehensive understanding of market value with the product price, demand, gross margin, and supply of the Chromatography Resin for Pharmaceuticals & Biotechnology Application Market. The competitive perspective section of the report presents a clear insight into the market share analysis of the major players in the industry.

See how the research methodology work for the report | request sample report:https://market.us/report/chromatography-resin-for-pharmaceuticals-biotechnology-application-market/request-sample/

*** NOTE: Our team of industry researchers are studying Covid-19 (Omicron) and its impact on the growth of the Chromatography Resin for Pharmaceuticals & Biotechnology Application Market and where necessary we will consider the Covid-19 footmark for better analysis of the market and industries. Contact us cogently for more detailed information.***

Figure:

Competitive Spectrum Top Companies Participating in the Chromatography Resin for Pharmaceuticals & Biotechnology Application Market are:

Mitsubishi CorpThermo Fisher Scientific Inc.Danaher CorporationMerck KGaATosoh CorporationAvantor Inc.Bio-Rad Laboratories Inc.Sartorius Stedim Biotech SAPuroliteBio-Works TechnologiesOthers

Chromatography Resin for Pharmaceuticals & Biotechnology Application Market research report will be sympathetic for:

1. New Investors

2. Propose investors and private equity companies

3. Cautious business organizers and analysts

4. Intelligent network security Suppliers, Manufacturers and Distributors

5. Government and research organizations

6. Speculation / Business Research League

7. End-use industries And much more

Chromatography Resin for Pharmaceuticals & Biotechnology Application Market Segments Evaluated in the Report:

Product Overview:

Based on Product Type

Natural PolymersSynthetic PolymersInorganic Media

Classified Applications of Chromatography Resin for Pharmaceuticals & Biotechnology Application Market :

Based on Technique

Ion Exchange (IEX) ChromatographyAffinity ChromatographyHydrophobic Interaction Chromatography (HIC)Size Exclusion Chromatography (SEC)Multimodal ChromatographyOther Techniques

Do You Have Any Query Or Specific Requirement? Ask Our Industry Expert@https://market.us/report/chromatography-resin-for-pharmaceuticals-biotechnology-application-market/#inquiry

Key regions divided during this report:

The Middle East and Africa Chromatography Resin for Pharmaceuticals & Biotechnology Application Market (Saudi Arabia, United Arab Emirates, Egypt, Nigeria, South Africa)

North America Chromatography Resin for Pharmaceuticals & Biotechnology Application Market (United States, Canada, Mexico)

Asia Pacific Chromatography Resin for Pharmaceuticals & Biotechnology Application Market (China, Japan, Korea, India, Southeast Asia)

South America Chromatography Resin for Pharmaceuticals & Biotechnology Application Market (Brazil, Argentina, Colombia)

Europe Chromatography Resin for Pharmaceuticals & Biotechnology Application Market (Germany, UK, France, Russia, Italy)

The Chromatography Resin for Pharmaceuticals & Biotechnology Application Market research is sourced for experts in both primary and developed statistics and includes qualitative and quantitative details. The analysis is derived Manufacturers experts work around the clock to recognize current circumstances, such as COVID-19, the possible financial reversal, the impact of a trade slowdown, the importance of the limitation on export and import, and all the other factors that may increase or decrease market growth during the forecast period.

TOC Highlights:

Chapter 1. Introduction

The Chromatography Resin for Pharmaceuticals & Biotechnology Application Market research work report covers a brief introduction to the global market. this segment provides opinions of key participants, an audit of Chromatography Resin for Pharmaceuticals & Biotechnology Application Market industry, outlook across key regions, financial services and various challenges faced by Chromatography Resin for Pharmaceuticals & Biotechnology Application Market. This section depends on the Scope of the Study and Report Guidance.

Chapter 2. Outstanding Report Scope

This is the second most important chapter, which covers market segmentation along with a definition of Chromatography Resin for Pharmaceuticals & Biotechnology Application Market. It defines the entire scope of the Chromatography Resin for Pharmaceuticals & Biotechnology Application Market report and the various facets it is describing.

Chapter 3. Market Dynamics and Key Indicators

This chapter includes key dynamics focusing on drivers[ Includes Globally Growing Chromatography Resin for Pharmaceuticals & Biotechnology Application Market Prevalence and Increasing Investments in Chromatography Resin for Pharmaceuticals & Biotechnology Application Market, Key Market Restraints [High Cost of Chromatography Resin for Pharmaceuticals & Biotechnology Application Market], opportunities [Emerging Markets in Developing Countries] and also presented in detail the emerging trends [Consistent Launch of New Screening Products] growth challenges, and influence factors shared in this latest report.

Chapter 4. Type Segments

This Chromatography Resin for Pharmaceuticals & Biotechnology Application Market report shows the market growth for various types of products marketed by the most comprehensive companies.

Chapter 5. Application Segments

The examiners who wrote the report have fully estimated the market potential of key applications and recognized future opportunities.

Chapter 6. Geographic Analysis

Each regional market is carefully scrutinized to understand its current and future growth, development, and demand scenarios for this market.

Chapter 7. Impact of COVID-19(Omicron)Pandemic on Global Chromatography Resin for Pharmaceuticals & Biotechnology Application Market

7.1 North America: Insight On COVID-19 (Omicron) Impact Study 2021

7.2 Europe: Serves Complete Insight On COVID-19 (Omicron) Impact Study 2021

7.3 Asia-Pacific: Potential Impact of COVID-19 (Omicron)

7.4 Rest of the World: Impact Assessment of COVID-19 (Omicron) Pandemic

Chapter 8. Manufacturing Profiles

The major players in the Chromatography Resin for Pharmaceuticals & Biotechnology Application Market are detailed in the report based on their market size, market served, products, applications, regional growth, and other factors.

Chapter 9. Pricing Analysis

This chapter provides price point analysis by region and other forecasts.

Chapter 10. North America Chromatography Resin for Pharmaceuticals & Biotechnology Application Market Analysis

This chapter includes an assessment on Chromatography Resin for Pharmaceuticals & Biotechnology Application Market product sales across major countries of the United States and Canada along with a detailed segmental outlook across these countries for the forecasted period 2022-2031.

Chapter 11. Latin America Chromatography Resin for Pharmaceuticals & Biotechnology Application Market Analysis

Major countries of Brazil, Chile, Peru, Argentina, and Mexico are assessed apropos to the adoption of Chromatography Resin for Pharmaceuticals & Biotechnology Application Market.

Chapter 12. Europe Chromatography Resin for Pharmaceuticals & Biotechnology Application Market Analysis

Market Analysis of Chromatography Resin for Pharmaceuticals & Biotechnology Application Market report includes insights on supply-demand and sales revenue of Chromatography Resin for Pharmaceuticals & Biotechnology Application Market across Germany, France, United Kingdom, Spain, BENELUX, Nordic and Italy.

Chapter 13. Asia Pacific Excluding Japan (APEJ) Chromatography Resin for Pharmaceuticals & Biotechnology Application Market Analysis

Countries of Greater China, ASEAN, India, and Australia & New Zealand are assessed and sales assessment of Chromatography Resin for Pharmaceuticals & Biotechnology Application Market in these countries is covered.

Chapter 14. Middle East and Africa (MEA) Chromatography Resin for Pharmaceuticals & Biotechnology Application Market Analysis

This chapter focuses on Chromatography Resin for Pharmaceuticals & Biotechnology Application Market scenario across GCC countries, Israel, South Africa, and Turkey.

Chapter 15. Research Methodology

The research methodology chapter includes the following main facts,

15.1 Coverage

15.2 Secondary Research

15.3 Primary Research

Chapter 16. Conclusion

Browse Full Report with Facts and Figures of Chromatography Resin for Pharmaceuticals & Biotechnology Application Market Report at:https://market.us/report/chromatography-resin-for-pharmaceuticals-biotechnology-application-market/

Get in Touch with Us :

Mr. Lawrence John

Market.us (Powered By Prudour Pvt. Ltd.)

Send Email:inquiry@market.us

Address:420 Lexington Avenue, Suite 300 New York City, NY 10170, United States

Tel:+1 718 618 4351

Website:https://market.us

Blog:https://techmarketreports.com/

Get More Reports Here:

Enteral Stents Market 2021 Report Explores Key Players Profiles and Sales Data to 2031

Flavonoids Market Study Reveals Size For Emerging Segments by 2031

Automotive Solar Film Market Statistics Based on Facts and Figures, 2022 to 2031

Pour Point Depressant Market Recent Development with Covid-19 Effect Analysis by Top Companies in 2021

Centrifuge Extractors Market Challenges and Opportunities for Stakeholders Focus on Growth Strategies up to 2031

Condenser Fan Motors Market Business Growth based on Expectations and Growth Trends Highlighted Until 2031

L-Lysine Market Objectives of the Study Includes Research Methodology and Assumptions and Forecast by 2031

Safety Glasses Market Growth Key Factors Focus on CAGR Status, Leading Trends, Forecast to 2031

Continued here:
Chromatography Resin for Pharmaceuticals & Biotechnology Application Market 2022 Size, Share, Revenue, Growth Opportunities, Trends and Demand by...

Wockhardt Limited, the Pharmaceutical and Biotechnology major, reported its 3rd Quarter Results for Financial Year 2021-22, today – marketscreener.com

Quarter on Quarter improvement in EBITDA in current year.

The Company recorded substantial growth in Revenue (up by 12% over previous corresponding quarter) and in EBITDA at Rs.114 crore compared to a profit of Rs.56 crore in the corresponding quarter of the previous year. There is Revenue growth of 21% in 9MFY22 over the previous year and substantial improvement in EBITDA at Rs.331 cr.

Rights issue - Plan to raise upto Rs. 1,000 Crore

The objective of the Issue is to, inter alia, meet the Company's financing needs for repayment of subordinated debt due, financing research and development initiatives, general corporate purposes and/or such other use of proceeds as may be permitted under the applicable laws.

The rights issue provides shareholders who have supported us all these years, an opportunity to further participate in Wockhardt's Strategic Plan for future growth. The rights issue proceeds will also strengthen Wockhardt's balance sheet, enhance its credit profile and provide financial flexibility to capture future growth in line with its Strategic Plan.

RDIF and Wockhardt partner to produce Sputnik V and Sputnik

Light vaccines against COVID-19

The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), and Wockhardt Limited, a global pharmaceutical company headquartered in India, have partnered to produce and supply Sputnik V and Sputnik Light vaccines against COVID-19. The agreement was reached under the aegis of Enso Healthcare (part of Enso Group), RDIF's coordination partner for sourcing Sputnik V vaccines in India.

The single dose Sputnik Light vaccine demonstrated 79.4% efficacy according to analysed data taken from 28 days after the injection was administered as part of Russia's mass vaccination programme.

One-shot Sputnik Light vaccine demonstrates 70% efficacy against infection with the Delta variant during the first three months after vaccination. The vaccine is more than 75% effective among subjects under the age of 60. Sputnik Light also provides much higher efficacy against severe diseases and hospitalisations.

Sputnik V demonstrates 83.1% efficacy against the Delta variant of coronavirus - higher than many other vaccines. The vaccine shows 6 times reduction of infection risk. Sputnik V is also

94.4% effective against hospitalisations with 18 times reduction in hospitalisation risk.

Sputnik V is based on a proven and well-studied platform of human adenoviral vectors and uses two different vectors for the two shots in a course of vaccination, providing immunity with a longer duration than vaccines using the same delivery mechanism for both shots.

About Wockhardt

Wockhardt is a research based Global Pharmaceutical and Biotech company. Wockhardt's New Drug Discovery programme has focussed on unmet need of Anti-bacterial drugs that are effective against the menace of untreatable superbugs. Wockhardt is the only company in the world where USFDA has given QIDP Status (Qualified Infectious Disease Product) for 6 of our Anti-bacterial discovery programmes - 3 of them are Gram Negative and 3 Gram Positive effective against untreatable 'Superbugs'. It has a comprehensive Drug Discovery team and clinical organisation.

Wockhardt is employing over 5000 people and 27 nationalities with presence in USA, UK, Ireland, Switzerland, France, Mexico, Russia and many other countries. It has manufacturing and research facilities in India, USA & UK and a manufacturing facility in Ireland. Wockhardt has a significant presence in USA, Europe and India, with 81% of its global revenues coming from international businesses.

Contact:

Tel: +91-22-2653 4444

Original post:
Wockhardt Limited, the Pharmaceutical and Biotechnology major, reported its 3rd Quarter Results for Financial Year 2021-22, today - marketscreener.com

HanBio Therapeutics Announces the Completion of a US$40 Million Series A Financing Led by OrbiMed and Hankang Capital – PRNewswire

SHANGHAI, Jan. 28, 2022 /PRNewswire/ -- HanBio Therapeutics ("HanBio"), a biotechnology company committed to researching and developing next generation transformative medicines, today announced that it has completed a US$40 million Series A financing to advance the preclinical and clinical development of its series of innovative antibodies and other biologics products. This round of financing was jointly led by OrbiMed and Hankang Capital, followed by Yonghua Investment and Elikon Investment. Before the completion of this round of financing, HanBio was an early product research and development company incubated by Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. ("Sunshine Guojian"). The company's current pipeline includes three bispecific antibodies in the IND and pre-IND stages, and a variety of early-stage antibodies and other biologics products.

Dr. Zhenping Zhu, Founder, Chairman and Chief Executive Officer of HanBio, said, "We highly appreciate OrbiMed and Hankang Capital and the other investors for their recognition of HanBio's R&D capability, its innovative pipeline and overall development strategy. This round of funds will be used for preclinical research and clinical trials of our multiple antibody and bispecific antibody products, as well as the establishment of an efficient company management and R&D team. We expect to submit IND applications to the regulatory agencies in both China and the United States for three innovative bispecific antibody products in 2022. On the research front we will focus on exploring new therapeutic targets and modalities, and developing innovative medicines with better safety and efficacy profiles to the current standard treatment options."

Dr. Zhu has extensive experience and an excellent track record in the biopharmaceutical industrial field, including more than 28 years of research and management experience in several world-renowned pharmaceutical companies. Prior to founding HanBio, Dr. Zhu served as the President of R&D and Chief Scientific Officer of 3SBio Group. Before joining 3SBio, Dr. Zhu has served as Executive Vice President at Kadmon Holdings, Vice President and Global Head of Protein Sciences at Novartis Biologics, and Vice President of Research at ImClone Systems. Dr. Zhu has contributed greatly to the discovery and development of a number of therapeutic antibody products approved by the US FDA, European EMA and China NMPA; he is the patent inventor of both ramucirumab (CyramzaR) and necitumumab (PortrazzaR), and one of the main contributors to cetuximab (ErbituxR). Dr. Zhu has published more than 200 peer-reviewed scientific papers in international journals, and has applied for or obtained more than 150 patents in China, United States and other international territories.

Dr. Jing Lou, Chairman of Sunshine Guojian, said, "I am very glad that HanBio, as an early product R&D company incubated by Sunshine Guojian, is recognized by leading biotech investors. Sunshine Guojian is committed to working with the investors to fully support HanBio for the rapid development of the company's innovative products that will benefit cancer patients in China and around the world."

Dr. Steven Dasong Wang, Partner at OrbiMed, said, "Dr. Zhu is one of the pioneers and leaders in the global biopharmaceutical industry. Several antibody products he invented or greatly contributed to, including ramucirumab (CyramzaR) and cetuximab (ErbituxR), have become ones of the most prescribed biologics in the treatment of gastric and colorectal cancers, with total global annual sales nearing 3 billion US dollars. HanBio led by Dr. Zhu has impressed us with its holistic approach to target selection, antibody discovery and design, and clinical translation strategy with special focus on cancers of the human digestive system. We look forward to supporting the company in advancing product clinical development and achieving breakthroughs in the treatment of cancers with high prevalence in China."

Mr. Quanhong Yuan, Partner at Hankang Capital, said, "PD1/PDL1 antibodies have reshaped the landscape of cancer treatment, but they also face the problem of limited response rate. Combination therapies and bispecific antibodies represent a new wave of therapeutic modalities, and are expected to provide a breakthrough solution to the treatment of PD1/PD1 resistant tumors. Dr. Zhu and his team at HanBio have rich experience and excellent track record in the field of antibody drug R&D and tumor immunotherapy. We expect HanBio to achieve great success in the field of cancer treatment."

About HanBio Therapeutics

"Transformative Medicines by Innovation."HanBio Therapeutics is an innovative biotechnology company committed to researching and developing next generation transformative medicines to treat patients with serious diseases.

For more information, please contact:Zhenping Zhu, MD, PhDEmail:[emailprotected][emailprotected]

Tel:+1 347 327 0705 (USA) +011 86 186 1234 0399 (China)

SOURCE HanBio Therapeutics

Continue reading here:
HanBio Therapeutics Announces the Completion of a US$40 Million Series A Financing Led by OrbiMed and Hankang Capital - PRNewswire

human genetics | Description, Chromosomes, & Inheritance …

human genetics, study of the inheritance of characteristics by children from parents. Inheritance in humans does not differ in any fundamental way from that in other organisms.

The study of human heredity occupies a central position in genetics. Much of this interest stems from a basic desire to know who humans are and why they are as they are. At a more practical level, an understanding of human heredity is of critical importance in the prediction, diagnosis, and treatment of diseases that have a genetic component. The quest to determine the genetic basis of human health has given rise to the field of medical genetics. In general, medicine has given focus and purpose to human genetics, so the terms medical genetics and human genetics are often considered synonymous.

Britannica Quiz

Genetics Quiz

Who deduced that the sex of an individual is determined by a particular chromosome? How many pairs of chromosomes are found in the human body? Test your knowledge. Take this quiz.

A new era in cytogenetics, the field of investigation concerned with studies of the chromosomes, began in 1956 with the discovery by Jo Hin Tjio and Albert Levan that human somatic cells contain 23 pairs of chromosomes. Since that time the field has advanced with amazing rapidity and has demonstrated that human chromosome aberrations rank as major causes of fetal death and of tragic human diseases, many of which are accompanied by intellectual disability. Since the chromosomes can be delineated only during mitosis, it is necessary to examine material in which there are many dividing cells. This can usually be accomplished by culturing cells from the blood or skin, since only the bone marrow cells (not readily sampled except during serious bone marrow disease such as leukemia) have sufficient mitoses in the absence of artificial culture. After growth, the cells are fixed on slides and then stained with a variety of DNA-specific stains that permit the delineation and identification of the chromosomes. The Denver system of chromosome classification, established in 1959, identified the chromosomes by their length and the position of the centromeres. Since then the method has been improved by the use of special staining techniques that impart unique light and dark bands to each chromosome. These bands permit the identification of chromosomal regions that are duplicated, missing, or transposed to other chromosomes.

Micrographs showing the karyotypes (i.e., the physical appearance of the chromosome) of a male and a female have been produced. In a typical micrograph the 46 human chromosomes (the diploid number) are arranged in homologous pairs, each consisting of one maternally derived and one paternally derived member. The chromosomes are all numbered except for the X and the Y chromosomes, which are the sex chromosomes. In humans, as in all mammals, the normal female has two X chromosomes and the normal male has one X chromosome and one Y chromosome. The female is thus the homogametic sex, as all her gametes normally have one X chromosome. The male is heterogametic, as he produces two types of gametesone type containing an X chromosome and the other containing a Y chromosome. There is good evidence that the Y chromosome in humans, unlike that in Drosophila, is necessary (but not sufficient) for maleness.

Strands of human chromosomes.

A human individual arises through the union of two cells, an egg from the mother and a sperm from the father. Human egg cells are barely visible to the naked eye. They are shed, usually one at a time, from the ovary into the oviducts (fallopian tubes), through which they pass into the uterus. Fertilization, the penetration of an egg by a sperm, occurs in the oviducts. This is the main event of sexual reproduction and determines the genetic constitution of the new individual.

Human sex determination is a genetic process that depends basically on the presence of the Y chromosome in the fertilized egg. This chromosome stimulates a change in the undifferentiated gonad into that of the male (a testicle). The gonadal action of the Y chromosome is mediated by a gene located near the centromere; this gene codes for the production of a cell surface molecule called the H-Y antigen. Further development of the anatomic structures, both internal and external, that are associated with maleness is controlled by hormones produced by the testicle. The sex of an individual can be thought of in three different contexts: chromosomal sex, gonadal sex, and anatomic sex. Discrepancies between these, especially the latter two, result in the development of individuals with ambiguous sex, often called hermaphrodites. Homosexuality is unrelated to the above sex-determining factors. It is of interest that in the absence of a male gonad (testicle) the internal and external sex anatomy is always female, even in the absence of a female ovary. A female without ovaries will, of course, be infertile and will not experience any of the female developmental changes normally associated with puberty. Such a female will often have Turner syndrome.

If X-containing and Y-containing sperm are produced in equal numbers, then according to simple chance one would expect the sex ratio at conception (fertilization) to be half boys and half girls, or 1 : 1. Direct observation of sex ratios among newly fertilized human eggs is not yet feasible, and sex-ratio data are usually collected at the time of birth. In almost all human populations of newborns, there is a slight excess of males; about 106 boys are born for every100 girls. Throughout life, however, there is a slightly greater mortality of males; this slowly alters the sex ratio until, beyond the age of about 50 years, there is an excess of females. Studies indicate that male embryos suffer a relatively greater degree of prenatal mortality, so the sex ratio at conception might be expected to favour males even more than the 106 : 100 ratio observed at birth would suggest. Firm explanations for the apparent excess of male conceptions have not been established; it is possible that Y-containing sperm survive better within the female reproductive tract, or they may be a little more successful in reaching the egg in order to fertilize it. In any case, the sex differences are small, the statistical expectation for a boy (or girl) at any single birth still being close to one out of two.

During gestationthe period of nine months between fertilization and the birth of the infanta remarkable series of developmental changes occur. Through the process of mitosis, the total number of cells changes from 1 (the fertilized egg) to about 2 1011. In addition, these cells differentiate into hundreds of different types with specific functions (liver cells, nerve cells, muscle cells, etc.). A multitude of regulatory processes, both genetically and environmentally controlled, accomplish this differentiation. Elucidation of the exquisite timing of these processes remains one of the great challenges of human biology.

Read the original post:

human genetics | Description, Chromosomes, & Inheritance ...